EP 1735001 A2 20061227 - PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES COMPRISING A COMBINATION OF EPINASTINE AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE CRUDE DRUGS
Title (en)
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES COMPRISING A COMBINATION OF EPINASTINE AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE CRUDE DRUGS
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON HAUTERKRANKUNGEN MIT EINER KOMBINATION AUS EPINASTIN UND EIN ODER MEHR ZUSÄTZLICHEN MINERALIEN ODER EIN ODER MEHR ROHARZNEIMITTELN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES DESTINEES AU TRAITEMENT DE MALADIES DE LA PEAU CONTENANT UNE COMBINAISON D'EPINASTINE ET D'UN OU PLUSIEURS MINERAUX OU D'UNE OU PLUSIEURS MATIERES PREMIERES
Publication
Application
Priority
- EP 2005002947 W 20050319
- EP 04007079 A 20040324
- EP 04007080 A 20040324
- EP 05716230 A 20050319
Abstract (en)
[origin: WO2005089803A2] The present invention relates to pharmaceutical compositions for the treatment of skin diseases. Particularly, the compositions described in the present invention are highly effective for the treatment of skin diseases associated with allergic reactions among a variety of symptoms derived from skin diseases. These compositions comprise an antihistaminic-effective amount of epinastine or a pharmaceutically acceptable salt thereof and one or more additional pharmaceutically acceptable minerals or one or more pharmaceutically acceptable crude drugs. The compositions may also comprise pharmaceutically acceptable additives.
IPC 8 full level
A61K 45/06 (2006.01); A61K 31/5517 (2006.01); A61K 33/00 (2006.01); A61K 36/076 (2006.01); A61K 36/23 (2006.01); A61K 36/233 (2006.01); A61K 36/234 (2006.01); A61K 36/25 (2006.01); A61K 36/282 (2006.01); A61K 36/346 (2006.01); A61K 36/484 (2006.01); A61K 36/538 (2006.01); A61K 36/575 (2006.01); A61K 36/634 (2006.01); A61K 36/708 (2006.01); A61K 36/736 (2006.01); A61K 36/744 (2006.01); A61K 36/8994 (2006.01); A61K 36/90 (2006.01); A61K 36/9068 (2006.01); A61P 17/00 (2006.01)
CPC (source: EP)
A61K 31/5517 (2013.01); A61K 33/00 (2013.01); A61K 36/076 (2013.01); A61K 36/23 (2013.01); A61K 36/233 (2013.01); A61K 36/234 (2013.01); A61K 36/25 (2013.01); A61K 36/282 (2013.01); A61K 36/346 (2013.01); A61K 36/484 (2013.01); A61K 36/538 (2013.01); A61K 36/575 (2013.01); A61K 36/634 (2013.01); A61K 36/708 (2013.01); A61K 36/736 (2013.01); A61K 36/744 (2013.01); A61K 36/8994 (2013.01); A61K 36/90 (2013.01); A61K 36/9068 (2013.01); A61K 45/06 (2013.01); A61P 17/00 (2017.12); A61P 17/02 (2017.12); A61P 17/04 (2017.12); A61P 17/06 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 2005089803A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR LV MK YU
DOCDB simple family (publication)
WO 2005089803 A2 20050929; WO 2005089803 A3 20061116; AR 049876 A1 20060913; EP 1735001 A2 20061227; JP 2007530481 A 20071101; PE 20051158 A1 20060216
DOCDB simple family (application)
EP 2005002947 W 20050319; AR P050101140 A 20050323; EP 05716230 A 20050319; JP 2007504328 A 20050319; PE 2005000324 A 20050322